Long-term Interventional Follow-up Study of Children With Prader-Willi Syndrome Included in the OTBB3 Clinical Trial
Status:
Recruiting
Trial end date:
2025-04-01
Target enrollment:
Participant gender:
Summary
This study is a prospective, multicentre, interventional cohort study in children with PWS
over 4 years (no treatment administered). The duration of the preceding OTTB3 study is 26
weeks. An untreated cohort of children with PWS will be included at an age of 2 years and
followed up until an age of 4 years.
Regarding the untreated cohort, children with PWS born in France and too old to be recruited
in OTBB3 trial, principally those who were born within one year before the start of OTBB3
trial, will be offered to participate in this study. Infants born later who couldn't be
included in OTBB3 study will be also offered to participate.